Marcus Karia

Group Finance Director, London, UK

Marcus is the Group Finance Director of Arix Bioscience. He is responsible for the finance function and overseeing Arix’s financial affairs.

Marcus joined the company soon after inception in 2016 and has led the development of the group’s finance operations, as well as supporting Arix through its IPO. He sits on the board of Arix Capital Management, Arix’s regulated investment management subsidiary.

After qualifying as a Chartered Accountant with PricewaterhouseCoopers, Marcus held positions at LDC, the private equity arm of Lloyds Bank, and Bridges Fund Management, a leading impact investor.

Marcus holds a first class degree in Economics from the University of Nottingham and is a member of the Institute of Chartered Accountants in England and Wales.